Stay updated with breaking news from Nasdaq Mrna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss National Bank trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.9% during the fourth quarter, Holdings Channel reports. The fund owned 1,011,600 shares of the company’s stock after selling 30,700 shares during the period. Swiss National Bank’s holdings in Moderna were worth $100,604,000 as of its most recent filing with the […]
Swiss National Bank decreased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,011,600 shares of the company’s stock after selling 30,700 shares during the period. Swiss National Bank owned approximately 0.27% of Moderna worth $100,604,000 at […]
Amalgamated Bank lowered its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,510 shares of the company’s stock after selling 5,519 shares during the quarter. Amalgamated Bank’s holdings in Moderna were worth […]
Amalgamated Bank cut its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 6.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,510 shares of the company’s stock after selling 5,519 shares during the period. Amalgamated Bank’s holdings in […]
Moderna (NASDAQ:MRNA – Get Free Report) had its price target raised by analysts at Royal Bank of Canada from $125.00 to $135.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 8.00% from the […]